Overview

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

This is a multi-center study to evaluate the effects of SCE-B on nocturnal vasomotor symptoms. Study duration will be approximately 16 weeks; this includes a 4-week screening period and approximately 5 scheduled clinic visits. Participants will receive one of two strengths of SCE-B tablets plus matching placebo or placebo only, and will have a physical and gynecological exams that may include transvaginal ultrasound, endometrial biopsy and a pap smear. Participants will be asked to wear a monitoring device for a portion of the study and be asked to complete a daily dairy.

Phase:

Phase 4

Details

Lead Sponsor:

Duramed Research

Treatments:

Estrogens
Estrogens, Conjugated (USP)
Estrogens, conjugated synthetic A
Estrogens, conjugated synthetic B